SeqLL Inc. (SQL)

Overview News Price History Why SQL Down? Discussions Forecast Stock Split

SeqLL Inc. (SQL) current stock price is $0.00 with a 24-hour trading volume of 0. The stock decreased by -100.00% in the last 24 hours and declined by -100.00% in the past month. Looking at the chart, SQL stock price is below the pivot point level of $7.13, suggesting a potential bearish market, if it continues to fall close to the support level of $4.46, significant changes may happen. Moreover, exploring the underlying reasons why SQL is dropping is crucial for acquiring comprehensive view about the stock. SeqLL Inc. (SQL) stock has undergone a total of 1 stock split since its initial public offering which has affected the stock’s price and liquidity.

SeqLL Inc. Stock (SQL) Latest News

SeqLL Defers Proposed Cash and Stock Distributions to Stockholders in Connection With Proposed Acquisition

GlobeNewswire Inc.

Why Flux Power Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Benzinga

S&P 500 Moves Higher; Avinger Shares Jump

Benzinga

Why Nikola Shares Are Trading Higher By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Benzinga

Crude Oil Rises Over 1%; US Housing Market Index Falls In September

Benzinga

US Stocks Mostly Higher; Dow Gains Over 50 Points

Benzinga

SeqLL Inc. Stock (SQL) Financials Data

Revenue

Net Income

Cash Flow

Earnings per Share

SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. The company designs, develops, and manufactures genetic analysis technologies. It offers true single molecule sequencing (tSMS) platform, which offers a single molecule solution for DNA and RNA sequencing. The company has a collaboration agreement with Bernstein Laboratory, Ting Laboratory, The Jackson Laboratory for Genomic Medicine, Weizmann Institute of Science, True Bearing Diagnostics, Inc., and Tetracore, Inc. It serves academic and government institutions, hospitals and medical centers, pharmaceutical and biotechnology companies, and non-profit research organizations. The company was founded in 2013 and is based in Billerica, Massachusetts.